SkinHealth Systems Statistics

Total Valuation

SKIN has a market cap or net worth of $85.54 million. The enterprise value is $250.31 million.

Market Cap	85.54M
Enterprise Value	250.31M

Important Dates

The next estimated earnings date is Thursday, August 6, 2026, after market close.

Earnings Date	Aug 6, 2026
Ex-Dividend Date	n/a

Share Statistics

SKIN has 129.60 million shares outstanding. The number of shares has increased by 2.20% in one year.

Current Share Class	129.60M
Shares Outstanding	129.60M
Shares Change (YoY)	+2.20%
Shares Change (QoQ)	+3.11%
Owned by Insiders (%)	9.13%
Owned by Institutions (%)	46.37%
Float	65.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	14.26
PS Ratio	0.29
Forward PS	0.29
PB Ratio	1.54
P/TBV Ratio	n/a
P/FCF Ratio	3.01
P/OCF Ratio	2.96
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.96, with an EV/FCF ratio of 8.80.

EV / Earnings	n/a
EV / Sales	0.85
EV / EBITDA	17.96
EV / EBIT	n/a
EV / FCF	8.80

Financial Position

The company has a current ratio of 1.79, with a Debt / Equity ratio of 6.65.

Current Ratio	1.79
Quick Ratio	1.43
Debt / Equity	6.65
Debt / EBITDA	19.11
Debt / FCF	12.90
Interest Coverage	-0.46

Financial Efficiency

Return on equity (ROE) is -11.95% and return on invested capital (ROIC) is -4.93%.

Return on Equity (ROE)	-11.95%
Return on Assets (ROA)	-1.15%
Return on Invested Capital (ROIC)	-4.93%
Return on Capital Employed (ROCE)	-3.33%
Weighted Average Cost of Capital (WACC)	5.96%
Revenue Per Employee	$483,067
Profits Per Employee	-$10,675
Employee Count	613
Asset Turnover	0.52
Inventory Turnover	1.83

Taxes

In the past 12 months, SKIN has paid $2.51 million in taxes.

Income Tax	2.51M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.62% in the last 52 weeks. The beta is 1.07, so SKIN's price volatility has been similar to the market average.

Beta (5Y)	1.07
52-Week Price Change	-65.62%
50-Day Moving Average	0.73
200-Day Moving Average	1.24
Relative Strength Index (RSI)	46.06
Average Volume (20 Days)	1,427,837

Short Selling Information

The latest short interest is 14.06 million, so 10.85% of the outstanding shares have been sold short.

Short Interest	14.06M
Short Previous Month	16.25M
Short % of Shares Out	10.85%
Short % of Float	21.63%
Short Ratio (days to cover)	9.06

Income Statement

In the last 12 months, SKIN had revenue of $296.12 million and -$6.54 million in losses. Loss per share was -$0.15.

Revenue	296.12M
Gross Profit	192.22M
Operating Income	-10.58M
Pretax Income	-3.55M
Net Income	-6.54M
EBITDA	13.94M
EBIT	-10.58M
Loss Per Share	-$0.15

Full Income Statement

Balance Sheet

The company has $202.36 million in cash and $367.13 million in debt, giving a net cash position of -$164.77 million or -$1.27 per share.

Cash & Cash Equivalents	202.36M
Total Debt	367.13M
Net Cash	-164.77M
Net Cash Per Share	-$1.27
Equity (Book Value)	55.24M
Book Value Per Share	0.43
Working Capital	122.49M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $28.94 million and capital expenditures -$482,000, giving a free cash flow of $28.45 million.

Operating Cash Flow	28.94M
Capital Expenditures	-482,000
Depreciation & Amortization	24.52M
Net Borrowing	-193.52M
Free Cash Flow	28.45M
FCF Per Share	$0.22

Full Cash Flow Statement

Margins

Gross margin is 64.91%, with operating and profit margins of -3.57% and -2.04%.

Gross Margin	64.91%
Operating Margin	-3.57%
Pretax Margin	-1.20%
Profit Margin	-2.04%
EBITDA Margin	4.71%
EBIT Margin	-3.57%
FCF Margin	9.61%

Dividends & Yields

SKIN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.20%
Shareholder Yield	n/a
Earnings Yield	-7.65%
FCF Yield	33.26%

Analyst Forecast

The average price target for SKIN is $1.34, which is 103.03% higher than the current price. The consensus rating is "Hold".

Price Target	$1.34
Price Target Difference	103.03%
Analyst Consensus	Hold
Analyst Count	8
Revenue Growth Forecast (3Y)	1.33%
EPS Growth Forecast (3Y)	-19.12%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SKIN has an Altman Z-Score of -0.41 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.41
Piotroski F-Score	5